Vaccine used in Azerbaijan is effective against British strain - OFFICIAL
Health
- 18 March, 2021
- 09:02

The CoronoVAC vaccine produced by the Chinese company SinoVac, which is used against coronavirus infection in Azerbaijan, is also effective against new strains, the National Center for Hematology and Transfusion told Report.
501Y.V1 and B.1.1.7 (British version) were found in three samples analyzed by the Sars Cov-2 genome at the Center's Genetic Diagnostic Center.
Azerbaijan started the vaccination process on January 18. Vaccination is performed voluntarily and at state expense. To date, 468,826 people in the country have been vaccinated.
Latest News
13:21
Kazakhstan, Pakistan aim to boost trade to $1 billion annually
Other countries12:55
Samad Seyidov: Azerbaijan hasn't closed its doors to PACE, but demands respect for its position
Domestic policy12:51
Azerbaijan to launch multi-stage research on artificial rain technology
Infrastructure12:41
NATO confirms its air defenses helped intercept Russian drones over Poland
Other countries12:37
CICA members must be ready for tectonic shifts – Chinese expert
Foreign policy12:32
Average annual inflation in Azerbaijan in January-August amounted to 5.6%
Finance12:22
French police arrest dozens in 'Block Everything' protests
Other countries12:20
Baku Port capacity to increase to 2,600 TEU in two years
Energy12:14